Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

The Drill Down

EpisodeOct 21, 202148m

Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

The Drill Down

EpisodeOct 21, 202148m

A blood test for cancer? Adaptive Biotech founders Chad and Harlan Robins explain. (Yes, they’re brothers!) (ADPT) Tesla’s novel accounting treatment for non-existent Full Self Driving Cars (TSLA). AutoNation says car shortages will persist through 2023 (AN). The Incredible Shrinking IBM. The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

Top comments

The Drill Down is a daily podcast focused on business fundamentals of the biggest stock movers of the market day, hosted by veteran financial journalist Cory Johnson. Through insightful interviews with CEOs and investors, meaningful research and in-depth analysis, The Drill Down provides a clearer picture of what’s really going on under the hood at publicly traded companies. This is business news for business people.

Switch to the Fountain App

Open in Fountain